We are monitoring the impact of COVID-19 on Europe Ophthalmic Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 5301
Share on
Share on

Europe Ophthalmic Drugs Market Research Report - Segmented Therapeutic Class, Product Type, Distribution Channel, By Disease Indication, By Dosage Form, By Technology By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: August, 2019
ID: 5301
Pages: 145

Europe Ophthalmic Drugs Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe Ophthalmic Drugs market size is valued at around USD 8.3 billion in 2019. It is expected to grow at a CAGR of 4.9% to reach USD 10.54 billion by 2024 during the forecast period 2019-2024. It captures 25% of the global market share.

Ophthalmic drugs are used for the treatment of various eye disorders like cataract, glaucoma etc.

Increasing number of people suffering from glaucoma all over the world, high innovation in and heavy funding in the development of combination therapies are the major factors driving the growth of this market.

Adverse side-effects and long gestation periods in the development of new drugs are the factors hampering market growth.

This research report segmented and sub-segmented into the following categories:

  • By Therapeutic Class: Anti-inflammatory Drug, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, Anti-VEGF Agents, Others
  • By Product Type: Prescription Drugs, Over-the-Counter Drugs 
  • By Distribution Channel: Hospital Pharmacies, Online  Pharmacies, Independent Pharmacies & Drug Stores 
  • By Disease Indications: Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, Allergy, Uveitis, Others  
  • By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, Other Ophthalmic Drug Forms       
  • By Technology: Biologics, Cell Therapy, Gene Therapy, Drug Delivery, Small molecule, Others 
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Europe comes a close second however is likely to undergo sluggish growth till 2022. France is the leader in the European market.

Key players operating in the Europe Ophthalmic Drugs Market profiled in this report are Carl-Zeiss AG, Ellex Medical Lasers Ltd., Hoya Corporation, Novagali Pharma S A, Abbott Medical Optics, Inc., Essilor International S.A. Other players in the market include Insight Vision Inc., Nidek Co.Ltd, Topcon Corporation, and Ziemer Ophthalmic Systems AG.

1. Introduction          

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                

2. Research Methodology                    

                2.1 Introduction        

                2.2 Research Phases                      

         2.2.1 Secondary Research           

         2.2.2 Primary Research 

         2.2.3 Econometric Modelling      

         2.2.4 Expert Validation  

                2.3 Analysis Design  

                2.4 Study Timeline   

3. Overview                

                3.1 Executive Summary                

                3.2 Key Inferences  

                3.3 Epidemology       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers   

                4.2 Market Restraints                    

                4.3 Key Challenges  

                4.4 Current Opportunities in the Market       

5. Market Segmentation

                5.1 Therapeutic Class                     

         5.1.1 Introduction           

         5.1.2 Anti-inflammatory Drugs  

  5.1.2.1 Nonsteroidal Anti-inflammatory Drugs

  5.1.2.2 Steroids

         5.1.3 Anti-infective Drugs            

  5.1.3.1 Anti-fungal Drugs

  5.1.3.2 Anti-bacterial Drugs

  5.1.3.3 Others

         5.1.4 Anti-glaucoma Drugs          

  5.1.4.1 Alpha Agonist

  5.1.4.2 Beta Blockers

  5.1.4.3 Prostaglandin Analogs

  5.1.4.4 Combined Medication

  5.1.4.5 Others

         5.1.5 Anti-allergy Drugs

         5.1.6 Anti-VEGF Agents

         5.1.7 Others      

         5.1.8 Y-o-Y Growth Analysis, By Therapeutic Class            

         5.1.9 Market Attractiveness Analysis, By Therapeutic Class          

         5.1.10 Market Share Analysis, By Therapeutic Class         

                5.2 Product Type      

         5.2.1 Introduction           

         5.2.2 Prescription Drugs               

         5.2.3 Over-the-Counter Drugs   

         5.2.4 Y-o-Y Growth Analysis, By Product Type    

         5.2.5 Market Attractiveness Analysis, By Product Type  

         5.2.6 Market Share Analysis, By Product Type    

                5.3 Distribution Channel        

         5.3.1 Introduction           

         5.3.2 Hospital Pharmacies            

         5.3.3 Online  Pharmacies              

         5.3.4 Independent Pharmacies & Drug Stores    

         5.3.5 Y-o-Y Growth Analysis, By Distribution Channel      

         5.3.6 Market Attractiveness Analysis, By Distribution Channel    

         5.3.7  Market Share Analysis, By Distribution Channel     

                5.4 Disease Indications                 

         5.4.1 Introduction           

         5.4.2 Dry Eye     

         5.4.3 Glaucoma

         5.4.4 Infection/Inflammation     

         5.4.5 Retinal Disorders  

  5.4.5.1 Wet Age-related Macular Degeneration

  5.4.5.2 Dry Age-related Macular Degeneration

  5.4.5.3 Diabetic Retinopathy

  5.4.5.4 Others

         5.4.6 Allergy      

         5.4.7 Uveitis      

         5.4.8 Others      

         5.4.9 Y-o-Y Growth Analysis, By Disease Indications         

         5.4.10 Market Attractiveness Analysis, By Disease Indications    

         5.4.11 Market Share Analysis, By Disease Indications      

                5.5 Dosage Form      

         5.5.1 Introduction           

         5.5.2 Liquid Ophthalmic Drug Forms        

         5.5.3 Solid Ophthalmic Drug Forms          

         5.5.4 Semisolid Ophthalmic Drug Forms

         5.5.5 Multicompartment Drug Delivery Systems               

         5.5.6 Other Ophthalmic Drug Forms        

         5.5.7 Y-o-Y Growth Analysis, By Dosage Form     

         5.5.8  Market Attractiveness Analysis, By Dosage Form  

         5.5.9  Market Share Analysis, By Dosage Form   

                5.6 Technology                 

         5.6.1 Introduction           

         5.6.2 Biologics   

         5.6.3 Cell Therapy           

         5.6.4 Gene Therapy       

         5.6.5 Drug Delivery         

         5.6.6 Small molecule      

         5.6.7 Others      

         5.6.8 Y-o-Y Growth Analysis, By Technology        

         5.6.9 Market Attractiveness Analysis, By Technology      

         5.6.10 Market Share Analysis, By Technology     

6. Geographical Analysis

                6.1 Introduction        

         6.1.1 Regional Trends    

         6.1.2 Impact Analysis     

         6.1.3 Y-o-Y Growth Analysis        

  6.1.3.1 By Geographical Area

  6.1.3.2 By Therapeutic Class

  6.1.3.3 By Product Type

  6.1.3.4 By Distribution Channel

  6.1.3.5 By Disease Indication

  6.1.3.6 By Dosage Form

  6.1.3.7 By Technology

         6.1.4  Market Attractiveness Analysis     

  6.1.4.1 By Geographical Area

  6.1.4.2 By Therapeutic Class

  6.1.4.3 By Product Type

  6.1.4.4 By Distribution Channel

  6.1.4.5 By Disease Indication

  6.1.4.6 By Dosage Form

  6.1.4.7 By Technology

         6.1.5  Market Share Analysis      

  6.1.5.1 By Geographical Area

  6.1.5.2 By Therapeutic Class

  6.1.5.3 By Product Type

  6.1.5.4 By Distribution Channel

  6.1.5.5 By Disease Indication

  6.1.5.6 By Dosage Form

  6.1.5.7 By Technology

                6.2 U.K                 

                6.3 Spain      

                6.4 Germany                     

                6.5 Italy        

                6.6 France   

7. Strategic Analysis                

                7.1 PESTLE analysis  

         7.1.1 Political     

         7.1.2 Economic 

         7.1.3 Social         

         7.1.4 Technological         

         7.1.5 Legal          

         7.1.6 Environmental       

                7.2 Porter’s Five analysis       

         7.2.1 Bargaining Power of Suppliers        

         7.2.2 Bargaining Power of Consumers    

         7.2.3 Threat of New Entrants     

         7.2.4 Threat of Substitute Products and Services              

         7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                 

                8.1 Abbott Medical Optics, Inc.                 

         8.1.1 Overview 

         8.1.2 Product Analysis   

         8.1.3 Financial analysis  

         8.1.4 Recent Developments       

         8.1.5 SWOT analysis       

         8.1.6 Analyst View          

                8.2 Carl-Zeiss AG      

                8.3 Ellex Medical Lasers Ltd.

                8.4 Essilor International S.A.

                8.5 Hoya Corporation                    

                8.6 Insight Vision Inc.                     

                8.7 Nidek Co.Ltd       

                8.8 Novagali Pharma S A        

                8.9 Topcon Corporation         

                8.10 Ziemer Ophthalmic Systems AG.                    

9. Competitive Landscape                    

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, collaborations and Joint Ventures  

                9.4 New Product Launches  

10. Market Outlook and Investment Opportunities                  

Appendix                    

                a) List of Tables                

                b) List of Figures       

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and Packaged Containers along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Ophthalmic Drugs  Market By Disease Indication, From 2019-2024 ( USD Billion )
  2. Europe Dry Eye Market By Region, From 2019-2024 ( USD Billion )
  3. Europe Glaucoma Market By Region, From 2019-2024 ( USD Billion )
  4. Europe Infection/Inflammation Market By Region, From 2019-2024 ( USD Billion )
  5. Europe Retinal Disorders Market By Region, From 2019-2024 ( USD Billion )
  6. Europe Allergy Market By Region, From 2019-2024 ( USD Billion )
  7. Europe Uveitis Market By Region, From 2019-2024 ( USD Billion )
  8. Europe Others Market By Region, From 2019-2024 ( USD Billion )
  9. Europe Ophthalmic Drugs  Market By Therapeutic Class, From 2019-2024 ( USD Billion )
  10. Europe Anti-inflammatory Drugs Market By Region, From 2019-2024 ( USD Billion )
  11. Europe Anti-infective Drugs Market By Region, From 2019-2024 ( USD Billion )
  12. Europe Anti-glaucoma Drugs Market By Region, From 2019-2024 ( USD Billion )
  13. Europe Anti-allergy Drugs Market By Region, From 2019-2024 ( USD Billion )
  14. Europe Anti-VEGF Agents Market By Region, From 2019-2024 ( USD Billion )
  15. Europe Others Market By Region, From 2019-2024 ( USD Billion )
  16. Europe Ophthalmic Drugs  Market By Product Type, From 2019-2024 ( USD Billion )
  17. Europe Prescription Drugs Market By Region, From 2019-2024 ( USD Billion )
  18. Europe Over-the-Counter Drugs Market By Region, From 2019-2024 ( USD Billion )
  19. Europe Ophthalmic Drugs  Market By Distribution Channel, From 2019-2024 ( USD Billion )
  20. Europe Hospital Pharmacies Market By Region, From 2019-2024 ( USD Billion )
  21. Europe Online Pharmacies Market By Region, From 2019-2024 ( USD Billion )
  22. Europe Independent Pharmacies & Drug Stores Market By Region, From 2019-2024 ( USD Billion )
  23. Europe Ophthalmic Drugs  Market By Dosage Form, From 2019-2024 ( USD Billion )
  24. Europe Liquid Ophthalmic Drug Forms Market By Region, From 2019-2024 ( USD Billion )
  25. Europe Solid Ophthalmic Drug Forms Market By Region, From 2019-2024 ( USD Billion )
  26. Europe Semisolid Ophthalmic Drug Forms Market By Region, From 2019-2024 ( USD Billion )
  27. Europe Multicompartment Drug Delivery Systems Market By Region, From 2019-2024 ( USD Billion )
  28. Europe Other Ophthalmic Drug Forms Market By Region, From 2019-2024 ( USD Billion )
  29. Europe Ophthalmic Drugs  Market By Technology, From 2019-2024 ( USD Billion )
  30. Europe Biologics Market By Region, From 2019-2024 ( USD Billion )
  31. Europe Cell Therapy Market By Region, From 2019-2024 ( USD Billion )
  32. Europe Gene Therapy Market By Region, From 2019-2024 ( USD Billion )
  33. Europe Drug Delivery Market By Region, From 2019-2024 ( USD Billion )
  34. Europe Small molecule Market By Region, From 2019-2024 ( USD Billion )
  35. Europe Others Market By Region, From 2019-2024 ( USD Billion )
  36. U.K. Ophthalmic Drugs  Market By Disease Indication, From 2019-2024 ( USD Billion )
  37. U.K. Ophthalmic Drugs  Market By Therapeutic Class, From 2019-2024 ( USD Billion )
  38. U.K. Ophthalmic Drugs  Market By Product Type, From 2019-2024 ( USD Billion )
  39. U.K. Ophthalmic Drugs  Market By Distribution Channel, From 2019-2024 ( USD Billion )
  40. U.K. Ophthalmic Drugs  Market By Dosage Form, From 2019-2024 ( USD Billion )
  41. U.K. Ophthalmic Drugs  Market By Technology, From 2019-2024 ( USD Billion )
  42. Germany Ophthalmic Drugs  Market By Disease Indication, From 2019-2024 ( USD Billion )
  43. Germany Ophthalmic Drugs  Market By Therapeutic Class, From 2019-2024 ( USD Billion )
  44. Germany Ophthalmic Drugs  Market By Product Type, From 2019-2024 ( USD Billion )
  45. Germany Ophthalmic Drugs  Market By Distribution Channel, From 2019-2024 ( USD Billion )
  46. Germany Ophthalmic Drugs  Market By Dosage Form, From 2019-2024 ( USD Billion )
  47. Germany Ophthalmic Drugs  Market By Technology, From 2019-2024 ( USD Billion )
  48. France Ophthalmic Drugs  Market By Disease Indication, From 2019-2024 ( USD Billion )
  49. France Ophthalmic Drugs  Market By Therapeutic Class, From 2019-2024 ( USD Billion )
  50. France Ophthalmic Drugs  Market By Product Type, From 2019-2024 ( USD Billion )
  51. France Ophthalmic Drugs  Market By Distribution Channel, From 2019-2024 ( USD Billion )
  52. France Ophthalmic Drugs  Market By Dosage Form, From 2019-2024 ( USD Billion )
  53. France Ophthalmic Drugs  Market By Technology, From 2019-2024 ( USD Billion )
  54. Italy Ophthalmic Drugs  Market By Disease Indication, From 2019-2024 ( USD Billion )
  55. Italy Ophthalmic Drugs  Market By Therapeutic Class, From 2019-2024 ( USD Billion )
  56. Italy Ophthalmic Drugs  Market By Product Type, From 2019-2024 ( USD Billion )
  57. Italy Ophthalmic Drugs  Market By Distribution Channel, From 2019-2024 ( USD Billion )
  58. Italy Ophthalmic Drugs  Market By Dosage Form, From 2019-2024 ( USD Billion )
  59. Italy Ophthalmic Drugs  Market By Technology, From 2019-2024 ( USD Billion )
  60. Spain Ophthalmic Drugs  Market By Disease Indication, From 2019-2024 ( USD Billion )
  61. Spain Ophthalmic Drugs  Market By Therapeutic Class, From 2019-2024 ( USD Billion )
  62. Spain Ophthalmic Drugs  Market By Product Type, From 2019-2024 ( USD Billion )
  63. Spain Ophthalmic Drugs  Market By Distribution Channel, From 2019-2024 ( USD Billion )
  64. Spain Ophthalmic Drugs  Market By Dosage Form, From 2019-2024 ( USD Billion )
  65. Spain Ophthalmic Drugs  Market By Technology, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample